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OBJECTIVE — Hyperglycemia is a common condition in hospitalized patients. The aim of
this study was to investigate the relationships between glycemia upon admission and mortality
in a heterogeneous group of adult patients.
RESEARCH DESIGN AND METHODS — The 3-year records released from a general
hospital were associated with a plasma glucose dataset of its general laboratory. A matched
case-control study was implemented (3,338 case-control subject pairs). All-patient reﬁned di-
agnosis–related groups and the relative risk of death were the matching criteria. A multivariate
conditional logistic regression model was used to evaluate the associations between death and
glycemia.
RESULTS — Higher in-hospital mortality was associated with hyperglycemia or hypoglyce-
mia, whereas lower risk was observed for values between 78 and 101 mg/dl.
CONCLUSIONS — Our data conﬁrm the relation between glycemia upon admission and
mortality and suggest that slightly increased or decreased plasma glucose can be linked with
increased mortality risk.
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H
yperglycemia is a common comor-
bid condition in hospitalized pa-
tients,independentofthediagnosis
ofdiabetes,andisassociatedwithadverse
outcomes (1–4). Although there is strong
evidence suggesting that tight glycemic
control is intimately linked to an im-
proved outcome in the intensive care unit
(5), hyperglycemia in hospitalized pa-
tients is generally not considered a major
therapeuticfocus.Itisimportanttodeter-
mine target plasma glucose concentra-
tions and glycemic thresholds associated
with optimal beneﬁts during hospitaliza-
tion. The aim of this study was to investi-
gatetherelationshipofplasmaglucoseon
admission with in-hospital mortality and
to identify the range of glycemic values
associated with signiﬁcant reductions of
mortality risks in a heterogeneous group
of hospitalized adult patients.
RESEARCH DESIGN AND
METHODS— Analyses included data
released from 96,405 patients hospital-
ized for different pathologies at San Gio-
vanni Battista Hospital of Turin, a large
teaching general hospital excluding de-
partments of ophthalmology, obstetrics
andgynecology,andpediatricsandinfec-
tious diseases, between 1 October 2003
and 30 September 2006. For every pa-
tient, administrative records were linked
withthelaboratorymeasurementsdataset
of plasma glucose. Of the 96,405 admis-
sions, 26,409 (27.4%) were excluded be-
cause plasma glucose was not measured
uponadmissiontothehospital.Fromthis
cohort, a matched case-control study was
implemented. Cases were deﬁned as in-
hospital deaths. All patients discharged
alive were considered control subjects.
Matching criteria were the all-patient re-
ﬁned diagnosis–related groups (APR-
DRGs) and their relative risk of death
(RISKD) (6). APR-DRGs are diagnosis-
related groups–based severity measure-
ment systems taking into consideration
the principal diagnosis, age, interactions
of multiple secondary diagnoses, and
combinations of nonoperating proce-
dures incorporated with the principal di-
agnosis of subjects. Among the 3,401
deaths, 63 records (62 with an APR-DRG
196, “Cardiac arrest, unexplained,” and 1
with APR-DRG 130, “Respiratory system
diagnosis with ventilator support 96
hours”) were excluded from the study be-
cause we could not ﬁnd a surviving con-
trol subject. A total of 3,338 cases were
thus matched with a random sample of
control subjects within each matching
stratum. This procedure led to a set of
6,676 patients perfectly balanced for APR
and RISKD distribution. All plasma glu-
cose measurements were determined in a
central laboratory with a glucose analyzer
(Roche/HitachiModularDanalyser:ACN
767, Indianapolis, IN). We performed a
multivariate conditional logistic regres-
sion model to evaluate the associations
between in-hospital mortality and a set of
variables including demographic charac-
teristics (sex, age, marital status, and level
of education) and clinical characteristics
(typeofadmission,typeoftreatment,and
plasma glucose on admission). APR-
DRGs and RISKD, as matching variables,
were not included in the model. All the
covariates were inserted in the model
without any formal selection. Plasma glu-
cose measurements were added to the
model as restricted cubic spline to inves-
tigate the association between in-hospital
deathandplasmaglucoselevelsthrougha
straight and smooth line outside the
whole interval of values. Nonlinearity of
the effects was eventually tested with a 
2
type test. Values of plasma glucose mini-
mizing the risk of death were determined
using the inverse spline function, and
95% CIs were derived from bootstraps
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dian and interquartile range and with
95% CIs whenever appropriate.
RESULTS— The whole population
with plasma glucose available at admis-
sion presents 69,996 cases (mean 65
years of age [range 51–75]; 42% female;
5%dead).Withinthisgroup,weanalyzed
a cohort of 3,338 cases (dead) versus
3,338 control subjects (alive) (mean 70
years of age [59–78] vs. 73 years of age
[63–80];40vs.42%female;andmean99
mg/dl [82–128] vs. 107 mg/dl [85–144]
plasma glucose on admission). The effect
ofplasmaglucoseadjustedbyadministra-
tion data was nonlinear, as described in
Fig. 1. Accordingly, the minimal risk of
in-hospital mortality was found at plasma
glucose levels of mean 89 mg/dl (range
78–101).Theadjustedoddsratio(OR)of
deaths for plasma glucose on admission
from 100 to 200 mg/dl is 1.32 (95% CI
1.22–1.43), whereas the OR for plasma
glucose from 60 to 80 mg/dl is 1.06
(1.04–1.07).
CONCLUSIONS — A signiﬁcant
numberofin-hospitalpatientsdisplayhy-
perglycemia, which can be the cause of
admission or, more frequently, comor-
bidity. Previous reports (7–9) have
pointed out the relationship between hy-
perglycemia and prognosis in critically ill
patients. The main novelty of the present
study is that even moderate glucose ele-
vations or reductions are associated with
increasedin-hospitalmortalityinthishet-
erogeneous population. In this study, we
have analyzed a large cohort of patients
hospitalizedformultiplepathologieswith
anestedcase-controlstudy.Furthermore,
ourobservationsstronglysuggestthat,in-
dependently of the cause of hospitaliza-
tion, a patient with an optimal plasma
glucose measure between 78 and 101
mg/dl displays lower risk of death. Inter-
estingly, this optimal glycemic range is
closely related to normoglycemic values
as deﬁned by criteria of the American Di-
abetes Association (10). The main limita-
tion of this study is its retrospective
nature. The retrospective design prevents
concludingwhetherhypo-orhyperglyce-
mia was a cause of increased mortality or
just a marker of increased risks of mortal-
ity, although we do observe a strong asso-
ciation between hospital mortality and
glycemic levels. Other limitations are 1)
missingdatafor27.4%ofalladmittedpa-
tients (this data gap could be the conse-
quence of the use of point-of-care
procedures)—in any case, within this
group, the mortality rate was only 3.5%;
2) some specialties were excluded from
the study because they were allocated to
other hospitals; 3) we do not know the
duration of hypo- or hyperglycemia; and
4) hypoglycemic values could result from
diabetestherapyorcriticaldiseases.How-
ever,thesedataconﬁrmtheimportanceof
glycemic value upon hospital admission
(11). Lowest hospital mortality rates were
observed among patients with plasma
glucose concentrations between 78 and
101 mg/dl, and even a moderate variation
below or above these cutoff values may
increase mortality in a heterogeneous
group of patients.
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Figure 1—Effect of plasma glucose values at admission in hospital (black line) on risk of in-
hospital death (log odds) and 95% CIs (dotted lines) adjusted by sex, civil status, age, educational
levels, type of admission, and type of treatment.
Normal glucose values and lower mortality
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